Drs. Kristen Scarpato, David Ambinder Discuss Salvage Therapy Options for BCR Prostate Cancer

By Kristen Scarpato, MD, MPH, David Ambinder, MD - May 1, 2023

At an American Urological Association plenary session, a panel of experts debated salvage therapy options after RT failure for a patient with biochemically recurrent (BCR) prostate cancer. The panel weighed the pros and cons of surgery, cryotherapy, high intensity focused ultrasound, and ADT/observation.

David Ambinder, MD, New York Medical College/Westchester Medical Center, interviewed panelist Kristen Scarpato, MD, MPH, Vanderbilt University Medical Center, on when focal therapy and other treatment options should be recommended in this patient population.

View more AUA 2023 meeting coverage.